Azacitidine for Pre-Emptive Treatment of Measurable-Residual Disease in   MDS/AML Patients at High Risk of Hematological Relapse: Results of the   Second Cohort of the RELAZA2 Trial

Platzbecker, Uwe; Middeke, Jan Moritz; Sockel, Katja; Herbst, Regina; Fransecky, Lars R.; Wolf, Dominik; Martin, Schumacher; Kramer, Alwin; Noppeney, Richard; Novotny, Juergen; Bug, Gesine; Gotze, Katharina; Spiekermann, Karsten; Stelljes, Matthias; Groth, Christoph; Subklewe, Marion; Schubert, Antje; Mutherig, Anke; Bochtler, Tilmann; Mende, Marika; Kubasch, Anne Sophie; Hanel, Mathias; Duhrsen, Ulrich; Schetelig, Johannes; Rollig, Christoph; Baldus, Claudia D.; Ehninger, Gerhard; Mueller-Tidow, Carsten; Serve, Hubert; Kramer, Michael; Bornhauser, Martin; Thiede, Christian

doi:10.1182/blood-2019-129926

2019

Back
Back to start of result list
Permanent link for displayed object

Document type:: Meeting Abstract
Author(s):: Platzbecker, Uwe; Middeke, Jan Moritz; Sockel, Katja; Herbst, Regina; Fransecky, Lars R.; Wolf, Dominik; Martin, Schumacher; Kramer, Alwin; Noppeney, Richard; Novotny, Juergen; Bug, Gesine; Gotze, Katharina; Spiekermann, Karsten; Stelljes, Matthias; Groth, Christoph; Subklewe, Marion; Schubert, Antje; Mutherig, Anke; Bochtler, Tilmann; Mende, Marika; Kubasch, Anne Sophie; Hanel, Mathias; Duhrsen, Ulrich; Schetelig, Johannes; Rollig, Christoph; Baldus, Claudia D.; Ehninger, Gerhard; Mueller-Tidow, Carsten; Serve, Hubert; Kramer, Michael; Bornhauser, Martin; Thiede, Christian «
Platzbecker, Uwe; Middeke, Jan Moritz; Sockel, Katja; Herbst, Regina; Fransecky, Lars R.; Wolf, Dominik; Martin, Schumacher; Kramer, Alwin; Noppeney, Richard; Novotny, Juergen; Bug, Gesine; Gotze, Katharina; Spiekermann, Karsten; Stelljes, Matthias; Groth, Christoph; Subklewe, Marion; Schubert, Antje; Mutherig, Anke; Bochtler, Tilmann; Mende, Marika; Kubasch, Anne Sophie; Hanel, Mathias; Duhrsen, Ulrich; Schetelig, Johannes; Rollig, Christoph; Baldus, Claudia D.; Ehninger, Gerhard; Mueller-Tidow... »
Title:: Azacitidine for Pre-Emptive Treatment of Measurable-Residual Disease in MDS/AML Patients at High Risk of Hematological Relapse: Results of the Second Cohort of the RELAZA2 Trial
Journal title abbreviation:: Blood
Year:: 2019
Journal volume:: 134 Suppl 1
Fulltext / DOI:: doi:10.1182/blood-2019-129926
Print-ISSN:: 0006-4971
TUM Institution:: III. Medizinische Klinik und Poliklinik (Hämatologie / Onkologie)
BibTeX

Occurrences:

mediaTUM Gesamtbestand Einrichtungen Schools TUM School of Medicine and Health Departments Clinical Medicine Klinik und Poliklinik für Innere Medizin III, Hämatologie und Onkologie (Prof. Bassermann)2019